The pump’s flow restrictor piece on flawed devices may become displaced and allow a higher rate of medication to be dispersed, which could cause death or other serious consequences, according to the release.
Affected kits were distributed between Sept. 10, 2012, and Feb. 11, 2013. Symbios is asking customers to set this product aside, complete a verification form and return the product.
More Articles on Anesthesia:
FDA: Merck Post-Anesthesia Drug Approval Delayed Three Months
Study: Anesthesia May Agitate Patients With Xeroderma Disorder
3-Step Preoperative System Promotes Positive Outcomes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
